BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 17511816)

  • 1. Candida krusei--a serious complication in patients with hematological malignancies: successful treatment with caspofungin.
    Conen A; Weisser M; Jörg CO; Battegay M; Trampuz A; Frei R; Christen S; Heim D; Gratwohl A; Flückiger U
    Transpl Infect Dis; 2008 Feb; 10(1):66-70. PubMed ID: 17511816
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Invasive candidiasis in cancer patients: observations from a randomized clinical trial.
    DiNubile MJ; Hille D; Sable CA; Kartsonis NA
    J Infect; 2005 Jun; 50(5):443-9. PubMed ID: 15907554
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Caspofungin for the treatment of candidaemia in patients with haematological malignancies.
    Pagano L; Fianchi L; Fanci R; Candoni A; Caira M; Posteraro B; Morselli M; Valentini CG; Farina G; Mitra ME; Offidani M; Sanguinetti M; Tosti ME; Nosari A; Leone G; Viale P
    Clin Microbiol Infect; 2010 Mar; 16(3):298-301. PubMed ID: 19549221
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Breakthrough C. parapsilosis and C. guilliermondii blood stream infections in allogeneic hematopoietic stem cell transplant recipients receiving long-term caspofungin therapy.
    Kabbara N; Lacroix C; Peffault de Latour R; Socié G; Ghannoum M; Ribaud P
    Haematologica; 2008 Apr; 93(4):639-40. PubMed ID: 18379015
    [No Abstract]   [Full Text] [Related]  

  • 5. Caspofungin for the treatment of invasive fungal disease in hematological patients (ProCAS Study).
    Jarque I; Tormo M; Bello JL; Rovira M; Batlle M; Julià A; Tabares S; Rivas C; Fernández-Sevilla A; García-Boyero R; Debén G; González-Campos J; Capote FJ; Sanz MA;
    Med Mycol; 2013 Feb; 51(2):150-4. PubMed ID: 22712457
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Candida glabrata and Candida krusei fungemia after high-risk allogeneic marrow transplantation: no adverse effect of low-dose fluconazole prophylaxis on incidence and outcome.
    Safdar A; van Rhee F; Henslee-Downey JP; Singhal S; Mehta J
    Bone Marrow Transplant; 2001 Nov; 28(9):873-8. PubMed ID: 11781648
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Successful treatment of an infant infected with refractory C. parapsilosis with caspofungin.
    Ozkaya-Parlakay A; Tezer H; Kazmacan T; Gulhan B; Unal S
    J Trop Pediatr; 2014 Aug; 60(4):329-30. PubMed ID: 24567311
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Candida krusei fungemia in an unrelated allogeneic hematopoietic stem cell transplant patient successfully treated with Caspofungin.
    Fanci R; Guidi S; Bonolis M; Bosi A
    Bone Marrow Transplant; 2005 Jun; 35(12):1215-6. PubMed ID: 15852027
    [No Abstract]   [Full Text] [Related]  

  • 9. Primary antifungal prophylaxis with micafungin in patients with haematological malignancies: real-life data from a retrospective single-centre observational study.
    Nachbaur D; Angelova O; Orth-Höller D; Ditlbacher A; Lackner M; Auberger J; Lass-Flörl C
    Eur J Haematol; 2015 Mar; 94(3):258-64. PubMed ID: 25082655
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Successful treatment with caspofungin of refractory Candida krusei candidemia in a very low birth weight preterm infant.
    Natale F; Castronovo A; Regoli D; De Curtis M; Manzoni P
    Pediatr Infect Dis J; 2009 May; 28(5):452. PubMed ID: 19295457
    [No Abstract]   [Full Text] [Related]  

  • 11. Successful treatment of Candida spp. encephalitis occurring under Caspofungin treatment after allogeneic stem cell transplantation.
    Behre G; Christopeit M; Weber T
    Ann Hematol; 2009 Jan; 88(1):93-4. PubMed ID: 18668242
    [No Abstract]   [Full Text] [Related]  

  • 12. Outcomes with micafungin in patients with candidaemia or invasive candidiasis due to Candida glabrata and Candida krusei.
    Shorr AF; Wu C; Kothari S
    J Antimicrob Chemother; 2011 Feb; 66(2):375-80. PubMed ID: 21147825
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Successfully treated Candida krusei infection of the lumbar spine with combined caspofungin/posaconazole therapy.
    Schilling A; Seibold M; Mansmann V; Gleissner B
    Med Mycol; 2008 Feb; 46(1):79-83. PubMed ID: 17852716
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Killing rates exerted by caspofungin in 50 % serum and its correlation with in vivo efficacy in a neutropenic murine model against Candida krusei and Candida inconspicua.
    Kovács R; Gesztelyi R; Berényi R; Domán M; Kardos G; Juhász B; Majoros L
    J Med Microbiol; 2014 Feb; 63(Pt 2):186-194. PubMed ID: 24184471
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Successful treatment of Candida krusei infection with caspofungin acetate: a new antifungal agent.
    McGee WT; Tereso GJ
    Crit Care Med; 2003 May; 31(5):1577-8. PubMed ID: 12771636
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Breakthrough Candida krusei fungemia during fluconazole prophylaxis followed by breakthrough zygomycosis during caspofungin therapy in a patient with severe aplastic anemia who underwent stem cell transplantation.
    Girmenia C; Moleti ML; Micozzi A; Iori AP; Barberi W; Foà R; Martino P
    J Clin Microbiol; 2005 Oct; 43(10):5395-6. PubMed ID: 16208029
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Caspofungin use in patients with invasive candidiasis caused by common non-albicans Candida species: review of the caspofungin database.
    Colombo AL; Ngai AL; Bourque M; Bradshaw SK; Strohmaier KM; Taylor AF; Lupinacci RJ; Kartsonis NA
    Antimicrob Agents Chemother; 2010 May; 54(5):1864-71. PubMed ID: 20231388
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Triple antifungal therapy for severe systemic candidiasis allowed performance of allogeneic stem cell transplantation.
    Gahn B; Schub N; Repp R; Gramatzki M
    Eur J Med Res; 2007 Aug; 12(8):337-40. PubMed ID: 17933709
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Successful intensive chemotherapy followed by autologous hematopoietic cell transplantation in a patient with acute myeloid leukemia and hepatosplenic candidiasis: case report and review of literature.
    Poon LM; Chia HY; Tan LK; Liu TC; Koh LP
    Transpl Infect Dis; 2009 Apr; 11(2):160-6. PubMed ID: 19228346
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Successful treatment with caspofungin of an invasive candidosis resistant to liposomal amphotericin B in a neutropenic patient].
    Rome A; André N; Michel A; Coze C; Gentet JC; Bernard JL
    Arch Pediatr; 2006 Dec; 13(12):1556-7. PubMed ID: 17049216
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.